nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—Serum amylase increased—Vandetanib—thyroid cancer	0.157	0.166	CcSEcCtD
Didanosine—Musculoskeletal disorder—Vandetanib—thyroid cancer	0.0462	0.0488	CcSEcCtD
Didanosine—Amylase increased—Vandetanib—thyroid cancer	0.0346	0.0366	CcSEcCtD
Didanosine—Nephropathy—Vandetanib—thyroid cancer	0.0346	0.0366	CcSEcCtD
Didanosine—Amylase increased—Sorafenib—thyroid cancer	0.0234	0.0247	CcSEcCtD
Didanosine—PNP—Erlotinib—Vandetanib—thyroid cancer	0.0208	0.392	CbGdCrCtD
Didanosine—Lactic acidosis—Epirubicin—thyroid cancer	0.0168	0.0178	CcSEcCtD
Didanosine—Lactic acidosis—Doxorubicin—thyroid cancer	0.0156	0.0165	CcSEcCtD
Didanosine—Dry eye—Vandetanib—thyroid cancer	0.0152	0.0161	CcSEcCtD
Didanosine—PNP—Afatinib—Vandetanib—thyroid cancer	0.0136	0.256	CbGdCrCtD
Didanosine—Rhabdomyolysis—Sorafenib—thyroid cancer	0.0126	0.0133	CcSEcCtD
Didanosine—Hypoglycaemia—Vandetanib—thyroid cancer	0.0123	0.013	CcSEcCtD
Didanosine—Drug interaction—Sorafenib—thyroid cancer	0.012	0.0127	CcSEcCtD
Didanosine—PNP—Gefitinib—Vandetanib—thyroid cancer	0.0119	0.224	CbGdCrCtD
Didanosine—Neuropathy—Sorafenib—thyroid cancer	0.0104	0.011	CcSEcCtD
Didanosine—Pancreatitis—Vandetanib—thyroid cancer	0.0101	0.0107	CcSEcCtD
Didanosine—Leukoderma—Epirubicin—thyroid cancer	0.00967	0.0102	CcSEcCtD
Didanosine—Hyperglycaemia—Vandetanib—thyroid cancer	0.00934	0.00986	CcSEcCtD
Didanosine—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00924	0.00976	CcSEcCtD
Didanosine—Hepatic failure—Sorafenib—thyroid cancer	0.00899	0.00949	CcSEcCtD
Didanosine—Leukoderma—Doxorubicin—thyroid cancer	0.00895	0.00945	CcSEcCtD
Didanosine—Renal failure acute—Sorafenib—thyroid cancer	0.00875	0.00924	CcSEcCtD
Didanosine—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00873	0.00922	CcSEcCtD
Didanosine—Abdominal pain upper—Sorafenib—thyroid cancer	0.00738	0.00779	CcSEcCtD
Didanosine—Alopecia—Vandetanib—thyroid cancer	0.00732	0.00773	CcSEcCtD
Didanosine—Pancreatitis—Sorafenib—thyroid cancer	0.00684	0.00723	CcSEcCtD
Didanosine—Optic neuritis—Epirubicin—thyroid cancer	0.00669	0.00706	CcSEcCtD
Didanosine—Optic neuritis—Doxorubicin—thyroid cancer	0.00619	0.00653	CcSEcCtD
Didanosine—Arthralgia—Vandetanib—thyroid cancer	0.00614	0.00648	CcSEcCtD
Didanosine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.0061	0.00644	CcSEcCtD
Didanosine—Dry mouth—Vandetanib—thyroid cancer	0.006	0.00634	CcSEcCtD
Didanosine—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00589	0.00622	CcSEcCtD
Didanosine—Infection—Vandetanib—thyroid cancer	0.00585	0.00617	CcSEcCtD
Didanosine—Hepatomegaly—Epirubicin—thyroid cancer	0.00581	0.00614	CcSEcCtD
Didanosine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00576	0.00609	CcSEcCtD
Didanosine—Neuritis—Epirubicin—thyroid cancer	0.00551	0.00582	CcSEcCtD
Didanosine—Hepatomegaly—Doxorubicin—thyroid cancer	0.00538	0.00568	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00536	0.00566	CcSEcCtD
Didanosine—Paraesthesia—Vandetanib—thyroid cancer	0.00528	0.00558	CcSEcCtD
Didanosine—Dyspepsia—Vandetanib—thyroid cancer	0.00518	0.00547	CcSEcCtD
Didanosine—Decreased appetite—Vandetanib—thyroid cancer	0.00512	0.0054	CcSEcCtD
Didanosine—Neuritis—Doxorubicin—thyroid cancer	0.0051	0.00538	CcSEcCtD
Didanosine—Pain—Vandetanib—thyroid cancer	0.00503	0.00531	CcSEcCtD
Didanosine—Alopecia—Sorafenib—thyroid cancer	0.00494	0.00521	CcSEcCtD
Didanosine—Blood disorder—Epirubicin—thyroid cancer	0.00492	0.0052	CcSEcCtD
Didanosine—Liver injury—Epirubicin—thyroid cancer	0.00489	0.00516	CcSEcCtD
Didanosine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00481	0.00508	CcSEcCtD
Didanosine—Abdominal pain—Vandetanib—thyroid cancer	0.00465	0.00491	CcSEcCtD
Didanosine—Body temperature increased—Vandetanib—thyroid cancer	0.00465	0.00491	CcSEcCtD
Didanosine—Blood disorder—Doxorubicin—thyroid cancer	0.00456	0.00481	CcSEcCtD
Didanosine—Liver injury—Doxorubicin—thyroid cancer	0.00452	0.00478	CcSEcCtD
Didanosine—Anaemia—Sorafenib—thyroid cancer	0.0045	0.00475	CcSEcCtD
Didanosine—Hyperuricaemia—Epirubicin—thyroid cancer	0.00443	0.00468	CcSEcCtD
Didanosine—Leukopenia—Sorafenib—thyroid cancer	0.00435	0.0046	CcSEcCtD
Didanosine—Inflammation—Epirubicin—thyroid cancer	0.00424	0.00448	CcSEcCtD
Didanosine—Asthenia—Vandetanib—thyroid cancer	0.00422	0.00446	CcSEcCtD
Didanosine—Blood uric acid increased—Epirubicin—thyroid cancer	0.00419	0.00442	CcSEcCtD
Didanosine—Pruritus—Vandetanib—thyroid cancer	0.00416	0.0044	CcSEcCtD
Didanosine—Myalgia—Sorafenib—thyroid cancer	0.00414	0.00437	CcSEcCtD
Didanosine—Arthralgia—Sorafenib—thyroid cancer	0.00414	0.00437	CcSEcCtD
Didanosine—Hepatocellular injury—Epirubicin—thyroid cancer	0.00411	0.00434	CcSEcCtD
Didanosine—Hyperuricaemia—Doxorubicin—thyroid cancer	0.0041	0.00433	CcSEcCtD
Didanosine—Dry mouth—Sorafenib—thyroid cancer	0.00405	0.00428	CcSEcCtD
Didanosine—Diarrhoea—Vandetanib—thyroid cancer	0.00403	0.00425	CcSEcCtD
Didanosine—Anaphylactic shock—Sorafenib—thyroid cancer	0.00397	0.00419	CcSEcCtD
Didanosine—Infection—Sorafenib—thyroid cancer	0.00394	0.00417	CcSEcCtD
Didanosine—Inflammation—Doxorubicin—thyroid cancer	0.00392	0.00414	CcSEcCtD
Didanosine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00389	0.0041	CcSEcCtD
Didanosine—Blood uric acid increased—Doxorubicin—thyroid cancer	0.00387	0.00409	CcSEcCtD
Didanosine—Neuropathy—Epirubicin—thyroid cancer	0.00386	0.00408	CcSEcCtD
Didanosine—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00381	0.00402	CcSEcCtD
Didanosine—Dry eye—Epirubicin—thyroid cancer	0.0038	0.00401	CcSEcCtD
Didanosine—Anorexia—Sorafenib—thyroid cancer	0.00378	0.004	CcSEcCtD
Didanosine—Vomiting—Vandetanib—thyroid cancer	0.00374	0.00395	CcSEcCtD
Didanosine—Rash—Vandetanib—thyroid cancer	0.00371	0.00392	CcSEcCtD
Didanosine—Dermatitis—Vandetanib—thyroid cancer	0.00371	0.00392	CcSEcCtD
Didanosine—Headache—Vandetanib—thyroid cancer	0.00369	0.00389	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00362	0.00382	CcSEcCtD
Didanosine—Neuropathy—Doxorubicin—thyroid cancer	0.00357	0.00377	CcSEcCtD
Didanosine—PNP—Daunorubicin—Epirubicin—thyroid cancer	0.00353	0.0665	CbGdCrCtD
Didanosine—Dry eye—Doxorubicin—thyroid cancer	0.00351	0.00371	CcSEcCtD
Didanosine—Nausea—Vandetanib—thyroid cancer	0.0035	0.00369	CcSEcCtD
Didanosine—Dyspepsia—Sorafenib—thyroid cancer	0.00349	0.00369	CcSEcCtD
Didanosine—Decreased appetite—Sorafenib—thyroid cancer	0.00345	0.00364	CcSEcCtD
Didanosine—Diabetes mellitus—Epirubicin—thyroid cancer	0.00343	0.00362	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00343	0.00362	CcSEcCtD
Didanosine—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00342	0.00361	CcSEcCtD
Didanosine—Pain—Sorafenib—thyroid cancer	0.00339	0.00359	CcSEcCtD
Didanosine—Hepatic failure—Epirubicin—thyroid cancer	0.00332	0.00351	CcSEcCtD
Didanosine—PNP—Daunorubicin—Doxorubicin—thyroid cancer	0.00326	0.0615	CbGdCrCtD
Didanosine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00325	0.00343	CcSEcCtD
Didanosine—Renal failure acute—Epirubicin—thyroid cancer	0.00323	0.00341	CcSEcCtD
Didanosine—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00318	0.00335	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00318	0.00335	CcSEcCtD
Didanosine—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00316	0.00334	CcSEcCtD
Didanosine—Body temperature increased—Sorafenib—thyroid cancer	0.00314	0.00331	CcSEcCtD
Didanosine—Abdominal pain—Sorafenib—thyroid cancer	0.00314	0.00331	CcSEcCtD
Didanosine—Renal impairment—Epirubicin—thyroid cancer	0.00314	0.00331	CcSEcCtD
Didanosine—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00308	0.00326	CcSEcCtD
Didanosine—Hepatic failure—Doxorubicin—thyroid cancer	0.00307	0.00325	CcSEcCtD
Didanosine—Hypoglycaemia—Epirubicin—thyroid cancer	0.00306	0.00323	CcSEcCtD
Didanosine—Renal failure acute—Doxorubicin—thyroid cancer	0.00299	0.00316	CcSEcCtD
Didanosine—Hypersensitivity—Sorafenib—thyroid cancer	0.00292	0.00309	CcSEcCtD
Didanosine—Renal impairment—Doxorubicin—thyroid cancer	0.0029	0.00306	CcSEcCtD
Didanosine—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00285	0.00301	CcSEcCtD
Didanosine—Asthenia—Sorafenib—thyroid cancer	0.00285	0.00301	CcSEcCtD
Didanosine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00283	0.00299	CcSEcCtD
Didanosine—Pruritus—Sorafenib—thyroid cancer	0.00281	0.00297	CcSEcCtD
Didanosine—Abdominal pain upper—Epirubicin—thyroid cancer	0.00273	0.00288	CcSEcCtD
Didanosine—Diarrhoea—Sorafenib—thyroid cancer	0.00272	0.00287	CcSEcCtD
Didanosine—Pancreatitis—Epirubicin—thyroid cancer	0.00253	0.00267	CcSEcCtD
Didanosine—Vomiting—Sorafenib—thyroid cancer	0.00252	0.00267	CcSEcCtD
Didanosine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00252	0.00266	CcSEcCtD
Didanosine—Rash—Sorafenib—thyroid cancer	0.0025	0.00264	CcSEcCtD
Didanosine—Dermatitis—Sorafenib—thyroid cancer	0.0025	0.00264	CcSEcCtD
Didanosine—Headache—Sorafenib—thyroid cancer	0.00249	0.00263	CcSEcCtD
Didanosine—Nausea—Sorafenib—thyroid cancer	0.00236	0.00249	CcSEcCtD
Didanosine—Pancreatitis—Doxorubicin—thyroid cancer	0.00234	0.00247	CcSEcCtD
Didanosine—Hyperglycaemia—Epirubicin—thyroid cancer	0.00233	0.00246	CcSEcCtD
Didanosine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00225	0.00238	CcSEcCtD
Didanosine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00218	0.0023	CcSEcCtD
Didanosine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00215	0.00227	CcSEcCtD
Didanosine—Agranulocytosis—Epirubicin—thyroid cancer	0.00215	0.00227	CcSEcCtD
Didanosine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00209	0.0022	CcSEcCtD
Didanosine—Hepatitis—Epirubicin—thyroid cancer	0.00207	0.00218	CcSEcCtD
Didanosine—Hypoaesthesia—Epirubicin—thyroid cancer	0.00205	0.00217	CcSEcCtD
Didanosine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00201	0.00213	CcSEcCtD
Didanosine—Agranulocytosis—Doxorubicin—thyroid cancer	0.00199	0.0021	CcSEcCtD
Didanosine—Hepatitis—Doxorubicin—thyroid cancer	0.00191	0.00202	CcSEcCtD
Didanosine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.0019	0.00201	CcSEcCtD
Didanosine—Chills—Epirubicin—thyroid cancer	0.00185	0.00196	CcSEcCtD
Didanosine—Alopecia—Epirubicin—thyroid cancer	0.00182	0.00193	CcSEcCtD
Didanosine—Flatulence—Epirubicin—thyroid cancer	0.00177	0.00187	CcSEcCtD
Didanosine—Chills—Doxorubicin—thyroid cancer	0.00171	0.00181	CcSEcCtD
Didanosine—Alopecia—Doxorubicin—thyroid cancer	0.00169	0.00178	CcSEcCtD
Didanosine—Anaemia—Epirubicin—thyroid cancer	0.00166	0.00175	CcSEcCtD
Didanosine—Flatulence—Doxorubicin—thyroid cancer	0.00164	0.00173	CcSEcCtD
Didanosine—Malaise—Epirubicin—thyroid cancer	0.00162	0.00171	CcSEcCtD
Didanosine—Leukopenia—Epirubicin—thyroid cancer	0.00161	0.0017	CcSEcCtD
Didanosine—Anaemia—Doxorubicin—thyroid cancer	0.00154	0.00162	CcSEcCtD
Didanosine—Myalgia—Epirubicin—thyroid cancer	0.00153	0.00162	CcSEcCtD
Didanosine—Arthralgia—Epirubicin—thyroid cancer	0.00153	0.00162	CcSEcCtD
Didanosine—Discomfort—Epirubicin—thyroid cancer	0.00151	0.0016	CcSEcCtD
Didanosine—Malaise—Doxorubicin—thyroid cancer	0.0015	0.00158	CcSEcCtD
Didanosine—Dry mouth—Epirubicin—thyroid cancer	0.0015	0.00158	CcSEcCtD
Didanosine—Leukopenia—Doxorubicin—thyroid cancer	0.00149	0.00157	CcSEcCtD
Didanosine—Anaphylactic shock—Epirubicin—thyroid cancer	0.00147	0.00155	CcSEcCtD
Didanosine—Infection—Epirubicin—thyroid cancer	0.00146	0.00154	CcSEcCtD
Didanosine—Thrombocytopenia—Epirubicin—thyroid cancer	0.00144	0.00152	CcSEcCtD
Didanosine—Arthralgia—Doxorubicin—thyroid cancer	0.00142	0.0015	CcSEcCtD
Didanosine—Myalgia—Doxorubicin—thyroid cancer	0.00142	0.0015	CcSEcCtD
Didanosine—Discomfort—Doxorubicin—thyroid cancer	0.0014	0.00148	CcSEcCtD
Didanosine—Anorexia—Epirubicin—thyroid cancer	0.0014	0.00148	CcSEcCtD
Didanosine—Dry mouth—Doxorubicin—thyroid cancer	0.00138	0.00146	CcSEcCtD
Didanosine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00136	0.00143	CcSEcCtD
Didanosine—Infection—Doxorubicin—thyroid cancer	0.00135	0.00142	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00134	0.00141	CcSEcCtD
Didanosine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00133	0.0014	CcSEcCtD
Didanosine—Paraesthesia—Epirubicin—thyroid cancer	0.00132	0.00139	CcSEcCtD
Didanosine—Anorexia—Doxorubicin—thyroid cancer	0.00129	0.00137	CcSEcCtD
Didanosine—Dyspepsia—Epirubicin—thyroid cancer	0.00129	0.00136	CcSEcCtD
Didanosine—Decreased appetite—Epirubicin—thyroid cancer	0.00128	0.00135	CcSEcCtD
Didanosine—Pain—Epirubicin—thyroid cancer	0.00125	0.00132	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00124	0.00131	CcSEcCtD
Didanosine—Paraesthesia—Doxorubicin—thyroid cancer	0.00122	0.00129	CcSEcCtD
Didanosine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.0012	0.00127	CcSEcCtD
Didanosine—Dyspepsia—Doxorubicin—thyroid cancer	0.0012	0.00126	CcSEcCtD
Didanosine—Decreased appetite—Doxorubicin—thyroid cancer	0.00118	0.00125	CcSEcCtD
Didanosine—Pain—Doxorubicin—thyroid cancer	0.00116	0.00123	CcSEcCtD
Didanosine—Body temperature increased—Epirubicin—thyroid cancer	0.00116	0.00122	CcSEcCtD
Didanosine—Abdominal pain—Epirubicin—thyroid cancer	0.00116	0.00122	CcSEcCtD
Didanosine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00111	0.00117	CcSEcCtD
Didanosine—Hypersensitivity—Epirubicin—thyroid cancer	0.00108	0.00114	CcSEcCtD
Didanosine—Body temperature increased—Doxorubicin—thyroid cancer	0.00107	0.00113	CcSEcCtD
Didanosine—Abdominal pain—Doxorubicin—thyroid cancer	0.00107	0.00113	CcSEcCtD
Didanosine—Asthenia—Epirubicin—thyroid cancer	0.00105	0.00111	CcSEcCtD
Didanosine—Pruritus—Epirubicin—thyroid cancer	0.00104	0.0011	CcSEcCtD
Didanosine—Diarrhoea—Epirubicin—thyroid cancer	0.001	0.00106	CcSEcCtD
Didanosine—Hypersensitivity—Doxorubicin—thyroid cancer	0.001	0.00106	CcSEcCtD
Didanosine—Asthenia—Doxorubicin—thyroid cancer	0.000974	0.00103	CcSEcCtD
Didanosine—Pruritus—Doxorubicin—thyroid cancer	0.00096	0.00101	CcSEcCtD
Didanosine—Vomiting—Epirubicin—thyroid cancer	0.000933	0.000985	CcSEcCtD
Didanosine—Diarrhoea—Doxorubicin—thyroid cancer	0.000929	0.000981	CcSEcCtD
Didanosine—Rash—Epirubicin—thyroid cancer	0.000925	0.000977	CcSEcCtD
Didanosine—Dermatitis—Epirubicin—thyroid cancer	0.000924	0.000976	CcSEcCtD
Didanosine—Headache—Epirubicin—thyroid cancer	0.000919	0.000971	CcSEcCtD
Didanosine—Nausea—Epirubicin—thyroid cancer	0.000871	0.00092	CcSEcCtD
Didanosine—Vomiting—Doxorubicin—thyroid cancer	0.000863	0.000912	CcSEcCtD
Didanosine—Rash—Doxorubicin—thyroid cancer	0.000856	0.000904	CcSEcCtD
Didanosine—Dermatitis—Doxorubicin—thyroid cancer	0.000855	0.000903	CcSEcCtD
Didanosine—Headache—Doxorubicin—thyroid cancer	0.00085	0.000898	CcSEcCtD
Didanosine—Nausea—Doxorubicin—thyroid cancer	0.000806	0.000852	CcSEcCtD
